Reduced vascular responses to soluble guanylyl cyclase but increased sensitivity to sildenafil in female rats with type 2 diabetes

Is chronic inhibition of phosphodiesterase type 5 cardioprotective and safe? A meta-analysis of randomized controlled trials

(2014) Elisa Giannetta et al.   BMC Medicine

PDE5 inhibitor efficacy is estrogen dependent in female heart disease

(2014) Hideyuki Sasaki et al.   JOURNAL OF CLINICAL INVESTIGATION

Advances in targeting cyclic nucleotide phosphodiesterases

(2014) Donald H. Maurice et al.   NATURE REVIEWS DRUG DISCOVERY

Augmented dilation to nitric oxide in uterine arteries from rats with type 2 diabetes: implications for vascular adaptations to pregnancy

(2013) Styliani Goulopoulou et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?

(2013) Karen E. Porter et al.   CLINICAL SCIENCE

Hyperglycemia-induced Oxidative Stress and its Role in Diabetes Mellitus Related Cardiovascular Diseases

(2013) Teresa Fiorentino et al.   CURRENT PHARMACEUTICAL DESIGN

Vascular smooth muscle function in type 2 diabetes mellitus: a systematic review and meta-analysis

(2013) David Montero et al.   DIABETOLOGIA

Type 2 Diabetes Mellitus and Hypertension

(2013) Guido Lastra et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Structure and Regulation of Soluble Guanylate Cyclase

(2012) Emily R. Derbyshire et al.   Annual Review of Biochemistry

Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy

(2012) Elisa Giannetta et al.   CIRCULATION

Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle

(2011) Manuel Morgado et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease

(2011) Johannes-Peter Stasch et al.   CIRCULATION

Effect of Phosphodiesterase Type 5 Inhibition on Microvascular Coronary Dysfunction in Women: A Women's Ischemia Syndrome Evaluation (WISE) Ancillary Study

(2011) Scott J. Denardo et al.   CLINICAL CARDIOLOGY

Internal Pudendal Artery from Type 2 Diabetic Female Rats Demonstrate Elevated Endothelin‐1‐Mediated Constriction

(2011) Kyan J. Allahdadi et al.   Journal of Sexual Medicine

Akt/eNOS pathway activation in endothelium-dependent relaxation is preserved in aortas from female, but not from male, type 2 diabetic mice

(2011) Kumiko Taguchi et al.   PHARMACOLOGICAL RESEARCH

Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions

(2011) Sharron H. Francis et al.   PHYSIOLOGICAL REVIEWS

Temporal changes in vascular reactivity in early diabetes mellitus in rats: role of changes in endothelial factors and in phosphodiesterase activity

(2009) K. Abboud et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Gender differences in tail-skin flushing induced by nitrates and phosphodiesterase type 5 inhibitors in a climacteric mouse model

(2009) Hitomi Sejima et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The GK rat beta-cell: A prototype for the diseased human beta-cell in type 2 diabetes?

(2008) B. Portha et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Uterine artery function in a mouse model of pregnancy complicated by diabetes

(2008) Joanna L. Stanley et al.   VASCULAR PHARMACOLOGY